Live Breaking News & Updates on Paratek Pharmaceuticals Company Profile Get Rating

Stay updated with breaking news from Paratek pharmaceuticals company profile get rating. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Critical Comparison: Paratek Pharmaceuticals (NASDAQ:PRTK) & IMV (NASDAQ:IMV)

Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) and IMV (NASDAQ:IMV – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, profitability, risk, institutional ownership and analyst recommendations. Analyst Ratings This is a breakdown of current ratings and […] ....

Tufts University , United States , Paratek Pharmaceuticals , Biomedical Advanced Research , Paratek Pharmaceuticals Inc , Development Authority , Immunovaccine Inc , Zai Lab Shanghai Co Ltd , Company Profile Get Rating , Tetraphase Pharmaceuticals Inc , Paratek Pharmaceuticals Company Profile Get Rating , Get Rating , Given Paratek Pharmaceutical , Pharmaceuticals Company Profile , Zai Lab , Tetraphase Pharmaceuticals , Nasdaq Prtk , Stock Comparison , Stock Analysis ,

Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Expected to Announce Earnings of -$0.35 Per Share

Analysts expect that Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK – Get Rating) will announce ($0.35) earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for Paratek Pharmaceuticals’ earnings, with the lowest EPS estimate coming in at ($0.35) and the highest estimate coming in at ($0.34). Paratek Pharmaceuticals reported earnings […] ....

Goldman Sachs Group Inc , Paratek Pharmaceuticals , Zacks Investment Research , Paratek Pharmaceuticals Inc , Worth Venture Partners , J Goldman Co , Paratek Pharmaceuticals Company Profile Get Rating , Get Rating , Paratek Pharmaceutical , Investment Research , Venture Partners , Springs Capital Management , Sachs Group , Street Corp , Pharmaceuticals Company Profile , Nasdaq Prtk ,

Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Expected to Post Earnings of -$0.35 Per Share

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock. ....

Goldman Sachs Group Inc , Paratek Pharmaceuticals , Zacks Investment Research , Blackrock Inc , Paratek Pharmaceuticals Inc , Invesco Ltd , Sg Americas Securities , Paratek Pharmaceuticals Company Profile Get Rating , Barclays Plc , Get Rating , Paratek Pharmaceutical , Investment Research , Goldman Sachs Group , Sachs Group , Pharmaceuticals Company Profile ,

Paratek Pharmaceuticals (NASDAQ:PRTK) versus Applied Therapeutics (NASDAQ:APLT) Critical Review

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock. ....

Tufts University , United States , New York , Paratek Pharmaceuticals , Biomedical Advanced Research , Therapeutics Company Profile Get Rating , Paratek Pharmaceuticals Inc , Zai Lab Shanghai Co Ltd , Development Authority , Therapeutics Inc , Tetraphase Pharmaceuticals Inc , Paratek Pharmaceuticals Company Profile Get Rating , Applied Therapeutics , Get Rating , Given Applied Therapeutic , Paratek Pharmaceutical , Therapeutics Company Profile , Pharmaceuticals Company Profile , Zai Lab , Tetraphase Pharmaceuticals ,

$27.15 Million in Sales Expected for Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) This Quarter

Wall Street brokerages expect Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK – Get Rating) to post sales of $27.15 million for the current fiscal quarter, Zacks reports. Two analysts have issued estimates for Paratek Pharmaceuticals’ earnings, with the lowest sales estimate coming in at $27.00 million and the highest estimate coming in at $27.30 million. Paratek Pharmaceuticals reported […] ....

Paratek Pharmaceuticals , Zacks Investment Research , Paratek Pharmaceuticals Inc , Cubist Systematic Strategies , Paratek Pharmaceuticals Company Profile Get Rating , Citigroup Inc , Campbell Co Investment Adviser , Wall Street , Get Rating , Paratek Pharmaceutical , Investment Research , Systematic Strategies , Summit Global Investments , Pharmaceuticals Company Profile , Nasdaq Prtk ,